Rosiglitazone is a superior bronchodilator compared to chloroquine and β-adrenoceptor agonists in mouse lung slices

BACKGROUND: Current therapy for relieving bronchoconstriction may be ineffective in severe asthma, particularly in the small airways. The aim of this study was to further characterise responses to the recently identified novel bronchodilators rosiglitazone (RGZ) and chloroquine (CQ) under conditions...

Descripción completa

Detalles Bibliográficos
Autores principales: Donovan, Chantal, Simoons, Mirjam, Esposito, James, Ni Cheong, Jean, FitzPatrick, Meaghan, Bourke, Jane Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995634/
https://www.ncbi.nlm.nih.gov/pubmed/24621080
http://dx.doi.org/10.1186/1465-9921-15-29

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995634/
https://www.ncbi.nlm.nih.gov/pubmed/24621080
http://dx.doi.org/10.1186/1465-9921-15-29

Ejemplares similares